Antares Pharma, Inc. (ATRS)

CapEx to Revenue

3.60%

TTM · Retrieved:

ATRS logo

ATRS CapEx to Revenue

Current (TTM)3.60%
ATRS CapEx/Revenue (11.02% → 3.60%)
High-resolution chart · PNG

ATRS capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
3.5965%
9.7695%
1.8972%
1.4067%
2.326%
9.5873%
14.6451%
21.3311%
15.3434%
15.5096%
3.5349%
1.6539%
2.257%
27.5013%
3.0822%
4.1808%
4.0297%
7.9403%
0.0306%
3.8827%
12.1209%
28.9544%
10.8484%
23.1205%
25.2127%
11.0193%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.